Camlin Fine Sciences Limited (CFS) has acquired a 78.68% stake in Vinpai, a France-based ingredient technology company, in a share-swap deal valued at ₹101.7 crore. The transaction involves issuing 41.06 lakh CFS shares at ₹247.69 per share, marking a strategic entry into the European market for natural food additives and functional ingredients. Founded in 2011, Vinpai specializes in plant, algae, mineral, and fiber-based ingredients used in food, cosmetics, and nutraceuticals, offering clean-label, sustainable alternatives to synthetic additives. The move aligns with CFS’s strategy to diversify its portfolio, enhance R&D capabilities, and tap into rising global demand for natural, health-focused products. Financially, CFS reported revenue growth of 14.39% to ₹1,681 crore and EBITDA up 27% to ₹222.6 crore in FY25, though net profit dipped 6.8% to ₹49.4 crore. The acquisition aims to drive future profitability through innovation and international scale. With Vinpai generating €9.2 million in revenue (FY24), the integration is expected to create synergies in technology, product development, and market reach—positioning CFS as a stronger player in the global specialty ingredients space.

CAMLINFINE

#WatchOutFor#StockInNews#FundamentalViews#SectorBreakouts#HiddenGems

945 likes·57 comments